(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(-0.60%) $83.35
(-1.16%) $1.619
(0.02%) $2 347.60
(0.93%) $27.51
(0.23%) $924.20
(-0.06%) $0.934
(-0.08%) $11.02
(-0.09%) $0.800
(0.00%) $92.17
@ $26.12
Utstedt: 10 apr 2024 @ 21:05
Avkastning: -5.51%
Forrige signal: apr 9 - 19:08
Forrige signal:
Avkastning: -2.68 %
Live Chart Being Loaded With Signals
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally...
Stats | |
---|---|
Dagens volum | 968 493 |
Gjennomsnittsvolum | 2.00M |
Markedsverdi | 4.12B |
EPS | $0 ( 2024-04-24 ) |
Neste inntjeningsdato | ( $0 ) 2024-07-22 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | 8.07 |
ATR14 | $0.0240 (0.10%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-11 | Lurker Nancy | Buy | 22 103 | Non Qualified Stock Option (Right to Buy) |
2024-04-11 | Lurker Nancy | Buy | 11 255 | Restricted Stock Unit Award |
2024-04-11 | Lurker Nancy | Buy | 4 833 | Non Qualified Stock Option (Right to Buy) |
2024-04-11 | Lurker Nancy | Buy | 2 323 | Restricted Stock Unit Award |
2024-03-18 | Nichols Christian Todd | Sell | 10 417 | Ordinary Shares |
INSIDER POWER |
---|
75.16 |
Last 99 transactions |
Buy: 1 207 179 | Sell: 170 568 |
Volum Korrelasjon
Alkermes Plc Korrelasjon
10 Mest positive korrelasjoner | |
---|---|
BLPH | 0.935 |
ETNB | 0.93 |
RCM | 0.928 |
XGN | 0.926 |
RNEM | 0.923 |
GMVD | 0.922 |
DBVT | 0.917 |
NUZE | 0.916 |
CGEN | 0.915 |
NVCT | 0.912 |
10 Mest negative korrelasjoner | |
---|---|
QADB | -0.914 |
WNEB | -0.905 |
EBACU | -0.899 |
MPRA | -0.898 |
PKOH | -0.898 |
DRNA | -0.898 |
JNCE | -0.895 |
MLAI | -0.892 |
SQQQ | -0.892 |
VS | -0.886 |
Visste du det?
Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).
Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.
Alkermes Plc Korrelasjon - Valuta/Råvare
Alkermes Plc Økonomi
Annual | 2023 |
Omsetning: | $1.66B |
Bruttogevinst: | $1.37B (82.64 %) |
EPS: | $2.14 |
FY | 2023 |
Omsetning: | $1.66B |
Bruttogevinst: | $1.37B (82.64 %) |
EPS: | $2.14 |
FY | 2022 |
Omsetning: | $1.11B |
Bruttogevinst: | $893.69M (80.38 %) |
EPS: | $-0.970 |
FY | 2021 |
Omsetning: | $1.17B |
Bruttogevinst: | $569.84M (48.55 %) |
EPS: | $-0.300 |
Financial Reports:
No articles found.
Alkermes Plc
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; VIVITROL for the treatment of alcohol and prevention of opioid dependence; RISPERDAL CONSTA for the treatment of schizophrenia and bipolar I disorder; INVEGA SUSTENNA for the treatment of schizophrenia and schizoaffective disorder; XEPLION, INVEGA TRINZA, and TREVICTA to treat schizophrenia and schizoaffective; and VUMERITY for the treatment of relapsing forms of multiple sclerosis in adults, including clinically isolated syndrome, relapsing-remitting and active secondary progressive diseases. The company is also developing LYBALVI, an oral atypical antipsychotic drug candidate for the treatment of adults with schizophrenia and bipolar I disorder; and nemvaleukin alfa, an engineered fusion protein to expand tumor-killing immune cells and to avoid the activation of immunosuppressive cells. It has collaboration agreements primarily with Janssen Pharmaceutica N.V., Janssen Pharmaceutica Inc, and Janssen Pharmaceutica International. Alkermes plc was founded in 1987 and is headquartered in Dublin, Ireland.
Om Live Signaler
Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.
Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.